The "Miracle in the Making" program is a testament to Faithful Fertility Collective's dedication to fostering hope and ...

Great Speech’s evidence-based virtual therapy model has supported patients with a wide range of communication challenges—from articulation and fluency to cognitive and social communication disorders.

H.H.C. Group IMRs offer several benefits, including protecting patients, improving internal review processes, and potentially reducing litigation. They also play a crucial role in ensuring compliance ...

Company to Host Conference Call, May 13, 2025 at 4:30 p.m. ET ...

After the transaction Saga Pure ASA and Ferncliff Listed Dai AS has no holding of shares in Vistin Pharma ASA. Øystein Stray Spetalen and associated parties have a holding of 331,886 shares in Vistin ...

Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced that the dispute between Route ...

The RapidPulse ® technology is a spin-out of Syntheon 2.0, LLC, an innovative medical device incubator with a long track record of successful exits. Other investors in RapidPulse include Santé ...

Pasithea Therapeutics, Corp. (“Pasithea,” or the “Company”) (Nasdaq: KTTA; KTTAW), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic MEK inhibitor, for the ...

CardiAMP HF II is Evaluating the CardiAMP™ Cell Therapy Product for Treating Patients with Ischemic Heart Failure of Reduced Ejection Fraction (HFrEF) and Elevated Markers of Cardiac Stress Dr. Amish ...

Daxor’s Innovative ezBVA Lab Service Drives Accessibility and Operational Efficiency ...

Title: Long-term Safety and Efficacy Data with Inhaled Pirfenidone (AP01) in the ATLAS Open-label Extension Study Up to 240 Weeks Authors: Tamera J. Corte, Sebastien Tilleux, Deepthi K. Nair, Felix A.

Vaxil announces that it will be consolidating all of the issued and outstanding common shares of the Company (" Common Shares ") on the basis of one (1) post consolidation Common Share for each fifty ...